AIDA OTC
Aida Pharmaceuticals, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +50.0%
3Y: -97.0%
5Y: -97.1%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$63M
+16.6% ▲
Total Liabilities
$42M
+8.5% ▲
Shareholders Equity
$13M
+28.6% ▲
Cash & Investments
$19M
+192.5% ▲
Total Debt
$33M
+12.9% ▲
Net Debt
$25M
+6.5% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2005 | FY2006 | FY2007 |
|---|---|---|---|
| — Assets — | |||
| Cash | $3M | $6M | $8M |
| Short-Term Investments | $0 | $363K | $11M |
| Cash & ST Investments | $3M | $6M | $19M |
| Net Receivables | $14M | $17M | $11M |
| Inventory | $3M | $3M | $4M |
| Other Current Assets | $2M | $3M | $415K |
| Total Current Assets | $22M | $29M | $36M |
| Property, Plant & Equip. | $13M | $14M | $17M |
| Goodwill & Intangibles | $4M | $9M | $9M |
| Long-Term Investments | $0 | $0 | $0 |
| Other Non-Current Assets | $4M | $1M | $205K |
| Total Non-Current Assets | $20M | $25M | $26M |
| Total Assets | $43M | $54M | $63M |
| — Liabilities — | |||
| Accounts Payable | $2M | $3M | $3M |
| Short-Term Debt | $21M | $28M | $32M |
| Deferred Revenue | $106K | $173K | $144K |
| Other Current Liabilities | $5M | $3M | $4M |
| Total Current Liabilities | $28M | $34M | $39M |
| Long-Term Debt | $4M | $6M | $2M |
| Other Non-Current Liab. | $0 | -$3M | $55K |
| Total Non-Current Liabilities | $4M | $4M | $3M |
| Total Liabilities | $32M | $38M | $42M |
| — Equity — | |||
| Common Stock | $150K | $27K | $27K |
| Retained Earnings | $3M | $5M | $7M |
| Accumulated OCI | $144K | $531K | $756K |
| Total Stockholders Equity | $7M | $10M | $13M |
| Total Liabilities & Equity | $43M | $54M | $63M |
| — Key Metrics — | |||
| Total Debt | $25M | $30M | $33M |
| Net Debt | $22M | $23M | $25M |
| Total Investments | $0 | $363K | $11M |